Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Effects of pravastatin and cholestyramine on circulating levels of parathyroid hormone and vitamin D metabolites.

Ismail F, Corder CN, Epstein S, Barbi G, Thomas S.

Clin Ther. 1990 Sep-Oct;12(5):427-30.

PMID:
2125243
4.

Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia.

Pan HY, DeVault AR, Swites BJ, Whigan D, Ivashkiv E, Willard DA, Brescia D.

Clin Pharmacol Ther. 1990 Aug;48(2):201-7.

PMID:
2116260
5.

Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels.

Wiklund O, Angelin B, Fager G, Eriksson M, Olofsson SO, Berglund L, Lindén T, Sjöberg A, Bondjers G.

J Intern Med. 1990 Sep;228(3):241-7.

PMID:
2119417
6.

[Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].

Ditschuneit HH, Dreyer M, Dammann HG, Ditschuneit H.

Med Klin (Munich). 1991 Mar 15;86(3):142-8. German.

PMID:
1903497
7.

A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.

Davidson MH, Testolin LM, Maki KC, von Duvillard S, Drennan KB.

Arch Intern Med. 1997 Jun 9;157(11):1186-92.

PMID:
9183229
8.

Effects of pravastatin treatment on vitamin D metabolites.

Montagnani M, Loré F, Di Cairano G, Gonnelli S, Ciuoli C, Montagnani A, Gennari C.

Clin Ther. 1994 Sep-Oct;16(5):824-9.

PMID:
7859242
9.

Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.

Milani M, Cimminiello C, Merlo B, Lorena M, Arpaia G, Bonfardeci G.

Am J Cardiol. 1995 Jul 13;76(2):51A-53A.

PMID:
7604798
10.

[Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].

Schwartzkopff W, Bimmermann A, Schleicher J.

Arzneimittelforschung. 1990 Dec;40(12):1322-7. German.

PMID:
2128866
13.

Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients.

Dobs AS, Miller S, Neri G, Weiss S, Tate AC, Shapiro DR, Musliner TA.

Metabolism. 2000 Jan;49(1):115-21.

PMID:
10647074
14.
15.

Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.

Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.

Climacteric. 2002 Dec;5(4):341-50.

PMID:
12626213
16.

Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia.

Santinga JT, Rosman HS, Rubenfire M, Maciejko JJ, Kobylak L, McGovern ME, Behounek BD.

Am J Med. 1994 Jun;96(6):509-15.

17.
19.

Comparison of fluvastatin versus pravastatin treatment of primary hypercholesterolemia. French Fluvastatin Study Group.

Jacotot B, Benghozi R, Pfister P, Holmes D.

Am J Cardiol. 1995 Jul 13;76(2):54A-56A.

PMID:
7604799
20.

Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.

Stender S, Schuster H, Barter P, Watkins C, Kallend D; MERCURY I Study Group.

Diabetes Obes Metab. 2005 Jul;7(4):430-8. Erratum in: Diabetes Obes Metab. 2005 Jul;7(4):460.

PMID:
15955130

Supplemental Content

Support Center